Pegylated interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4 in adolescents: A pilot study

被引：0
|
作者：
Hasan, Fuad
Alsarraf, Khalid
Qabandi, Wafa
机构：
来源：
GASTROENTEROLOGY | 2006年 / 130卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A840 / A840
页数：1
相关论文
共 50 条
  • [21] Pilot study of pegylated interferon alfa-2b and ribavirin for recurrent hepatitis C after liver transplantation
    Mukherjee, S
    Rogge, J
    Weaver, L
    Schafer, DF
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (08) : 3042 - 3044
  • [22] Efficacy of pegylated interferon alfa-2a or alfa-2b in combination with ribavirin in the treatment of chronic hepatitis caused by hepatitis C virus genotype 1b
    Mach, Tomasz H.
    Ciesla, Andrzej
    Warunek, Wioleta
    Janas-Skulina, Urszula
    Cibor, Dorota
    Owczarek, Danuta
    Ciecko-Michalska, Irena
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2011, 121 (12): : 434 - 439
  • [23] Peginterferon alfa-2b plus ribavirin for chronic hepatitis C virus infection genotype 4
    Shiha, Gamal
    Elshennaw, Hassan
    Abbas, Baha
    Khaled, Zalata
    Attia, Mohamed
    Farouk, Doaa
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A25 - A25
  • [24] Treatment of Recurrent Hepatitis C (Genotype 1) with Pegylated Interferon Alfa-2b and Ribavirin Combination and Maintenance Therapy
    Testino, Gianni
    Sumberaz, Alessandro
    Ansaldi, Filippo
    Borro, Paolo
    Leone, Silvia
    Ancarani, A. Ornella
    Gentile, Raffaella
    Icardi, Giancarlo
    HEPATO-GASTROENTEROLOGY, 2011, 58 (106) : 536 - 538
  • [25] Efficacy of combination weight-based therapy with pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C: Impact of genotype and race
    Thakkar, Shyam
    Alagugurusamy, Sankar
    Mehta, Vinay
    Loeffert, Martha
    Babich, Michael
    Agrawal, Radheshyam
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S176 - S176
  • [26] Cost-effectiveness of peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin as initial treatment of chronic hepatitis C in Belgium
    Wong, JB
    Nevens, F
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2002, 65 (02): : 110 - 111
  • [27] Treatment outcome in patients with chronic hepatitis C treated with different pegylated(PEG) interferon alfa-2b plus ribavirin regimens
    Zhang, YT
    Levendoglu, H
    JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (09): : 1033 - 1033
  • [28] Sustained antiviral response with consensus interferon (CIFN)plus ribavirin or interferon alfa-2b (IFN alfa-2b) plus ribavirin in treatment-naive subjects with chronic hepatitis C. A pilot study.
    Sjogren, MH
    Holtzmuller, K
    Smith, M
    Sjogren, R
    HEPATOLOGY, 2002, 36 (04) : 311A - 311A
  • [29] Peginterferon alfa-2b plus ribavirin versus interferon alfa-2b plus ribavirin for chronic hepatitis C in HIV-coinfected patients
    Crespo, M
    Sauleda, S
    Esteban, JI
    Juarez, A
    Buti, M
    Pahissa, A
    Esteban, R
    Guardia, J
    HEPATOLOGY, 2005, 42 (04) : 701A - 702A
  • [30] Pegylated Interferon Alfa-2a Plus Ribavirin in Chronic Hepatitis C Patients with Genotype 6
    Pham, Thuy T.
    Ho, Dat T.
    GASTROENTEROLOGY, 2009, 136 (05) : A840 - A840
12345